What's best for your patient with BPH?
Watchful waiting is recommended for patients with benign prostatic hyperplasia (BPH) whose clinical symptoms do not affect their quality of life. Use a validated patient questionnaire, such as the American Urological Association's Symptom Index, to establish the severity of BPH symptoms and follow their progression. alpha-Adrenergic blockers (either selective or nonselective) or 5-alpha reductase inhibitors are appropriate first-line therapies for patients bothered by BPH symptoms. Consider surgery for patients with severe obstructive symptoms who have not benefited from medical therapy or who prefer surgery as first-line treatment.
Neal
Randall H
RH
Offutt Air Force Base, Omaha, NE, USA.
Keister
Drew
D
D058891:5-alpha Reductase Inhibitors; D000317:Adrenergic alpha-Antagonists / Q000627:therapeutic use; D006801:Humans; D008297:Male; D011468:Prostatectomy; D011470:Prostatic Hyperplasia / Q000150:complications* / Q000175:diagnosis / Q000628:therapy*; D012720:Severity of Illness Index
D058891:5-alpha Reductase Inhibitors; D000317:Adrenergic alpha-Antagonists